Core Viewpoint - The article highlights the successful medical assistance provided by Tianjin's medical team to Tibetan patients suffering from severe knee pain, showcasing the advancements in robotic-assisted surgery and the ongoing medical support initiatives between Tianjin and Tibet [1][3][4]. Group 1: Patient Background - The patients, 64-year-old Tsering Zhongga and 56-year-old Ding Zeng, traveled nearly 4,000 kilometers from Dingqing County, Tibet, to Tianjin for treatment of severe knee osteoarthritis that had affected their quality of life for over a decade [1][3]. - Both patients experienced significant mobility issues, with walking becoming increasingly difficult, leading to a diagnosis of severe knee osteoarthritis and related complications [3][4]. Group 2: Surgical Procedure - The surgical team at Nankai University Affiliated Beichen Hospital, led by Dr. He Sen, opted for robotic-assisted bilateral total knee surface replacement surgery, which is designed to enhance recovery speed and patient comfort [4][5]. - The robotic system utilized preoperative 3D measurements and precise intraoperative maneuvers to maximize the protection of healthy tissue, making the surgery more personalized, precise, and minimally invasive [5]. Group 3: Medical Support Initiatives - Since establishing a support relationship in 2016, the hospital has sent numerous medical experts to Dingqing County, significantly improving local healthcare resources [5][6]. - The hospital has implemented a free assistance program for knee disease patients, successfully treating 46 patients from Dingqing County since 2021, reflecting a shift from merely providing resources to enhancing local medical capabilities [6].

Financial Data and Key Metrics Changes - In 2024, the company reported revenues of $19.7 billion, demonstrating robust margin expansion and earnings per share growth driven by a lean culture [14] - The company started 2025 with the highest backlog as an independent company, indicating strong momentum in orders and book-to-bill ratios [15] Business Line Data and Key Metrics Changes - The introduction of new products contributed to a three-year new product introduction vitality rate of approximately 50%, reflecting the impact of increased R&D commitment [15] - The company closed 50 strategic long-term enterprise deals globally in 2024, which provided future growth and recurring revenue [15][16] Market Data and Key Metrics Changes - Record double-digit orders growth was driven by strength in the U.S. market, particularly in imaging products focused on cardiology and oncology [17] - The company has a strong funnel of additional opportunities to offset the impact of tariffs, indicating resilience in a dynamic global trade environment [17] Company Strategy and Development Direction - The company is evolving from an imaging and critical care equipment provider to a healthcare solutions provider, focusing on co-creating holistic offerings that include technology, services, and solutions [14] - The disciplined M&A strategy is being executed to complement existing technologies and solutions, with recent acquisitions enhancing capabilities in AI-enabled imaging and radiopharmaceutical distribution [16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence that the impact of tariffs will be lower in 2026 compared to 2025, as the company has time to address supply chain structures [46] - The company is focused on sourcing closer to customers and has a global footprint with 43 manufacturing sites across 17 countries, providing flexibility in navigating tariff structures [46] Other Important Information - The company reported a healthy margin and earnings per share performance in the first quarter of 2025, reflecting strong commercial execution [16] - The Board of Directors recommended against a stockholder proposal regarding executive compensation, indicating a commitment to aligning management pay with shareholder interests [37] Q&A Session Summary Question: How has the current administration and tariffs affected GE Healthcare? - The gross impact of tariffs was over $1 billion, which was mitigated down to approximately $50 million, with expectations for further reduction in impact [45][46] Question: Have the on-off tariffs from Washington had any material effect on your company? - The company has been able to navigate the situation effectively, focusing on sourcing and manufacturing strategies to mitigate tariff impacts [46]